ESR1 and breast carcinoma: Instead, MTMR3 expression was lower in breast cancer tissues than in normal tissues, but it was heavily methylated, suggesting that the rs12537 mutation in patients with estrogen receptor-positive breast cancer may control MTMR3 methylation [18].